Legence Corp. (EXCHANGE:LGN) experienced sizable share disposals by holders of ten percent ownership on April 9, 2026, when 15,394,112 shares of Class A Common Stock were sold at a price of $54.00 per share, producing approximately $831 million in proceeds.
The two selling entities identified in filings were Legence Parent ML LLC and Legence Parent II ML LLC. Legence Parent ML LLC sold 9,528,699 shares while Legence Parent II ML LLC disposed of 5,865,413 shares. The per-share price for these sales was $54.00, consistent across the combined transaction.
On the same date Legence Parent ML LLC also carried out a conversion-like exchange, surrendering 9,528,699 Class B Units of Legence Holdings LLC along with an equal number of Class B Common Stock shares in exchange for the same number of Class A Common Stock shares.
These insider and affiliated-holder transactions coincided with other capital market activity for Legence. The company completed a secondary public offering of 15.4 million Class A common shares, priced at $54.00 per share, generating roughly $831 million in gross proceeds. That offering reflected the full exercise of the underwriters' option to purchase an additional 2.0 million shares.
Those shares in the completed offering were sold by stockholders affiliated with Blackstone Inc. Separately, Legence announced the pricing of another secondary offering by Blackstone-affiliated stockholders for 13,386,185 shares, with a 30-day option for underwriters to buy up to an additional 2,007,927 shares.
Market pricing and valuation context were also disclosed. Legence shares have risen 89% over the past year and were trading at $59.76, close to the 52-week high of $60.50. According to InvestingPro analysis cited in the filings, LGN appears overvalued versus its Fair Value and is listed among companies on InvestingPro's Most Overvalued list. The company’s Pro Research Report for LGN is available through InvestingPro as one of more than 1,400 such reports.
Analysts have responded to recent operating results and the company's public-market performance. Stifel raised its price target for Legence to $60 while maintaining a Buy rating, pointing to robust fourth-quarter 2025 results with emphasis on the Data Centers & Technology segment. RBC Capital increased its price target to $64 from $48 and kept an Outperform rating, citing that Legence’s revenue and adjusted EBITDA in its second quarter as a public company exceeded consensus estimates.
Taken together, the insider sales, the unit-for-stock exchange, the completed and priced secondary offerings, and analyst target changes mark a concentrated period of financing and shareholder activity for Legence. The reports and transactions set out here are those disclosed in public filings and analyst commentary; no additional outcomes or implications beyond the stated facts are offered.